Nanalysis Scientific Corp (NSCI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,126 | 1,694 | 759 | 1,271 | 4,953 |
| Receivables | 9,794 | 10,667 | 9,758 | 6,471 | 7,250 |
| Inventories | 4,786 | 4,827 | 5,794 | 7,167 | 8,226 |
| Other current assets | 2,015 | 1,804 | 1,603 | 1,471 | 1,846 |
| TOTAL | $17,721 | $18,992 | $17,914 | $16,380 | $22,275 |
| Non-Current Assets | |||||
| PPE Net | 4,083 | 4,458 | 4,737 | 4,424 | 6,371 |
| Investments And Advances | 5,292 | 5,527 | 5,727 | 5,998 | N/A |
| Intangibles | 21,110 | 21,414 | 21,642 | 21,624 | 40,722 |
| Other Non-Current Assets | 3,246 | 3,588 | 3,804 | 4,153 | 3,077 |
| TOTAL | $33,731 | $34,987 | $35,910 | $36,199 | $50,170 |
| Total Assets | $51,452 | $53,979 | $53,824 | $52,579 | $72,445 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,945 | 2,787 | 6,490 | 2,953 | 2,315 |
| Accounts payable and accrued liabilities | N/A | N/A | 5,081 | N/A | 5,792 |
| Other current liabilities | 371 | 520 | 428 | 814 | 730 |
| TOTAL | $12,508 | $12,707 | $14,596 | $10,778 | $11,438 |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,800 | 12,490 | 12,557 | 12,601 | 13,166 |
| Deferred Revenues | 1,093 | 1,612 | 1,321 | 1,205 | 1,466 |
| Other Non-Current Liabilities | 169 | 0 | 0 | 808 | -11,168 |
| TOTAL | $14,779 | $15,499 | $15,747 | $16,401 | $17,167 |
| Total Liabilities | $27,287 | $28,206 | $30,343 | $27,179 | $28,605 |
| Shareholders' Equity | |||||
| Common Shares | 57,558 | 57,558 | 53,201 | 53,062 | 53,063 |
| Retained earnings | -39,506 | -37,511 | -34,989 | -32,866 | -26,579 |
| Other shareholders' equity | 494 | 495 | 596 | 718 | 1,821 |
| TOTAL | $24,165 | $25,773 | $23,481 | $25,400 | $31,961 |
| Total Liabilities And Equity | $51,452 | $53,979 | $53,824 | $52,579 | $60,566 |